"Receptors, Cell Surface" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands.
| Descriptor ID |
D011956
|
| MeSH Number(s) |
D12.776.543.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Cell Surface".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Cell Surface".
- Receptors, Cell Surface
- Asialoglycoprotein Receptor
- Autoreceptors
- CD36 Antigens
- Cysteine Loop Ligand-Gated Ion Channel Receptors
- Endoglin
- Endothelial Protein C Receptor
- Folate Receptors, GPI-Anchored
- Junctional Adhesion Molecule A
- Methyl-Accepting Chemotaxis Proteins
- Netrin Receptors
- Neuropilins
- Nogo Receptors
- Patched Receptors
- Receptor for Advanced Glycation End Products
- Receptor Protein-Tyrosine Kinases
- Receptors, Adipokine
- Receptors, Artificial
- Receptors, Autocrine Motility Factor
- Receptors, Biogenic Amine
- Receptors, Collagen
- Receptors, Death Domain
- Receptors, G-Protein-Coupled
- Receptors, Guanylate Cyclase-Coupled
- Receptors, Immunologic
- Receptors, Lipoprotein
- Receptors, N-Acetylglucosamine
- Receptors, Neurotransmitter
- Receptors, Notch
- Receptors, Peptide
- Receptors, Phospholipase A2
- Receptors, Proteinase-Activated
- Receptors, Transferrin
- Receptors, Urokinase Plasminogen Activator
- Receptors, Virus
- Receptors, Wnt
- Zona Pellucida Glycoproteins
This graph shows the total number of publications written about "Receptors, Cell Surface" by people in this website by year, and whether "Receptors, Cell Surface" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 2 | 4 |
| 2004 | 3 | 1 | 4 |
| 2005 | 3 | 1 | 4 |
| 2006 | 0 | 2 | 2 |
| 2007 | 4 | 3 | 7 |
| 2008 | 3 | 1 | 4 |
| 2009 | 0 | 1 | 1 |
| 2010 | 3 | 2 | 5 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 1 | 3 |
| 2017 | 15 | 11 | 26 |
| 2018 | 21 | 9 | 30 |
| 2019 | 8 | 3 | 11 |
| 2020 | 3 | 5 | 8 |
| 2021 | 3 | 5 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Cell Surface" by people in Profiles.
-
ACE2, TMPRSS2, and L-SIGN Expression in Placentae From HIV-Positive Pregnancies Exposed to Antiretroviral Therapy-Implications for SARS-CoV-2 Placental Infection. J Infect Dis. 2021 Dec 08; 224(Supplement_6):S631-S641.
-
Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics? Emerg Microbes Infect. 2021 Dec; 10(1):1191-1199.
-
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021 10; 598(7880):342-347.
-
A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance. Elife. 2021 08 17; 10.
-
L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus. JCI Insight. 2021 07 22; 6(14).
-
Poly-l-lysine Glycoconjugates Inhibit DC-SIGN-mediated Attachment of Pandemic Viruses. ChemMedChem. 2021 08 05; 16(15):2345-2353.
-
An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism. Sci Rep. 2021 07 07; 11(1):14015.
-
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients. Clin Chem Lab Med. 2021 10 26; 59(11):e413-e415.
-
Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents. J Ethnopharmacol. 2021 Oct 05; 278:114303.
-
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. PLoS Pathog. 2021 05; 17(5):e1009576.